- Home
- JKHY vs ICLR Comparison
JKHY vs ICLR Comparison
Compare JKHY & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKHY
- ICLR
- Stock Information
- Founded
- JKHY 1976
- ICLR 1990
- Country
- JKHY United States
- ICLR Ireland
- Employees
- JKHY N/A
- ICLR N/A
- Industry
- JKHY Retail: Computer Software & Peripheral Equipment
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- JKHY Technology
- ICLR Health Care
- Exchange
- JKHY Nasdaq
- ICLR Nasdaq
- Market Cap
- JKHY 13.4B
- ICLR 15.7B
- IPO Year
- JKHY N/A
- ICLR 1998
- Fundamental
- Price
- JKHY $173.21
- ICLR $189.64
- Analyst Decision
- JKHY Buy
- ICLR Strong Buy
- Analyst Count
- JKHY 12
- ICLR 10
- Target Price
- JKHY $188.73
- ICLR $294.50
- AVG Volume (30 Days)
- JKHY 614.3K
- ICLR 2.1M
- Earning Date
- JKHY 11-05-2024
- ICLR 10-23-2024
- Dividend Yield
- JKHY 1.27%
- ICLR N/A
- EPS Growth
- JKHY 10.52
- ICLR 44.49
- EPS
- JKHY 5.47
- ICLR 8.99
- Revenue
- JKHY $2,245,157,000.00
- ICLR $8,306,823,000.00
- Revenue This Year
- JKHY $9.18
- ICLR $4.00
- Revenue Next Year
- JKHY $7.28
- ICLR $3.16
- P/E Ratio
- JKHY $31.66
- ICLR $21.10
- Revenue Growth
- JKHY 5.91
- ICLR 3.63
- 52 Week Low
- JKHY $151.05
- ICLR $188.57
- 52 Week High
- JKHY $189.63
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- JKHY 32.76
- ICLR 17.52
- Support Level
- JKHY $177.63
- ICLR $208.65
- Resistance Level
- JKHY $177.69
- ICLR $217.91
- Average True Range (ATR)
- JKHY 3.62
- ICLR 8.02
- MACD
- JKHY -1.40
- ICLR -1.46
- Stochastic Oscillator
- JKHY 10.03
- ICLR 2.32
About JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for us banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.